Clinvest
Quick facts
Marketed products
- almotriptan or pseudoephedrine · Neurology
This is a combination product containing almotriptan (a selective 5-HT1B/1D receptor agonist for migraine) and pseudoephedrine (a sympathomimetic nasal decongestant).
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:
Frequently asked questions about Clinvest
What are Clinvest's marketed drugs?
Top marketed products include almotriptan or pseudoephedrine.
Related
- almotriptan or pseudoephedrine · Neurology
- Sector hub: All tracked pharma companies